Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Electric Power Company Inc (AEP) vs ARK Genomic Revolution ETF (ARKG) Price & Performance

American Electric Power Company Inc
ARK Genomic Revolution ETF

Price performance

Price movement over the last 24 hours

Key statistics

American Electric Power Company Inc vs ARK Genomic Revolution ETF — how do they compare? American Electric Power Company Inc trades at $137.15 (market cap $74.83B), while ARK Genomic Revolution ETF trades at $41.16. The key difference: American Electric Power Company Inc pays a 2.76% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.

AEPARKG
Market Cap
$74.83B
Sector
UtilitiesSector/Thematic
52-Week High
$138.69$43.57
52-Week Low
$103.96$23.09
Enterprise Value
$126.09B
Dividend Yield
2.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Electric Power Company Inc

AEP trades at $137.53, down 0.71% on the day, with strong analyst support (64% buy ratings) and a $142.82 consensus price target. The stock shows bullish technical momentum with recent earnings beats and robust revenue growth, climbing from $19.7B in 2024 to $21.9B in 2025. AEP benefits from AI-driven electricity demand and a $78B capital plan for grid expansion.

Outlook remains positive given AEP's strategic positioning in energy infrastructure, though risks include high capital expenditures and debt levels. The current valuation at 20.12x P/E appears reasonable for a utility with stable earnings growth and dividend payments, supporting a constructive view for long-term investors.

ARK Genomic Revolution ETF

ARKG trades at $43.57, up 1.54% today, with strong technical momentum as moving averages signal bullish sentiment. The ETF benefits from positive biotech sector trends including FDA friendliness and M&A activity. However, key oscillators show neutral readings with RSI indicators suggesting overbought conditions near the $45 resistance level.

The biotech ETF outlook remains favorable amid sector strength, though elevated RSI levels indicate potential near-term consolidation. Investment opportunity lies in continued sector momentum, while risks include market volatility and selective investor sentiment toward biotech companies as noted by JPMorgan bankers in June 2026.

Returns comparison

Trailing returns across standard periods

About American Electric Power Company Inc

American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.

Read more on AEP

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG